Oxygen therapy in acute exacerbations of chronic obstructive pulmonary disease. 2015

Janine Pilcher, and Mark Weatherall, and Kyle Perrin, and Richard Beasley
Medical Research Institute of New Zealand, Private Bag 7902, Wellington 6242, New Zealand.

During the last decade, there have been major advances in knowledge of the effects of oxygen therapy in patients with acute exacerbations of chronic obstructive pulmonary disease. This includes a randomised controlled trial of oxygen therapy in the pre-hospital setting, which showed that high concentration oxygen therapy leads to a 2.4-fold increased risk of mortality compared with titrated oxygen therapy to maintain oxygen saturations (SpO2) within a target range of 88-92%. Professional guidelines now recommend the use of supplementary oxygen in acute exacerbations of chronic obstructive pulmonary disease only if the SpO2 is less than 88%, with titration to achieve an SpO2 of 88-92%, and the delivery of bronchodilators by air-driven nebulisation or metered dose inhaler with a spacer. The aim of this review is to provide an overview of the evidence base that underpins these recommendations. We suggest that their implementation will require important changes to current clinical practice in which there is an entrenched culture of the use of high concentration oxygen therapy.

UI MeSH Term Description Entries
D010102 Oxygen Inhalation Therapy Inhalation of oxygen aimed at restoring toward normal any pathophysiologic alterations of gas exchange in the cardiopulmonary system, as by the use of a respirator, nasal catheter, tent, chamber, or mask. (From Dorland, 27th ed & Stedman, 25th ed) Inhalation Therapy, Oxygen,Therapy, Oxygen Inhalation,Inhalation Therapies, Oxygen,Oxygen Inhalation Therapies,Therapies, Oxygen Inhalation
D001993 Bronchodilator Agents Agents that cause an increase in the expansion of a bronchus or bronchial tubes. Bronchial-Dilating Agents,Bronchodilator,Bronchodilator Agent,Broncholytic Agent,Bronchodilator Effect,Bronchodilator Effects,Bronchodilators,Broncholytic Agents,Broncholytic Effect,Broncholytic Effects,Agent, Bronchodilator,Agent, Broncholytic,Agents, Bronchial-Dilating,Agents, Bronchodilator,Agents, Broncholytic,Bronchial Dilating Agents,Effect, Bronchodilator,Effect, Broncholytic,Effects, Bronchodilator,Effects, Broncholytic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000280 Administration, Inhalation The administration of drugs by the respiratory route. It includes insufflation into the respiratory tract. Drug Administration, Inhalation,Drug Administration, Respiratory,Drug Aerosol Therapy,Inhalation Drug Administration,Inhalation of Drugs,Respiratory Drug Administration,Aerosol Drug Therapy,Aerosol Therapy, Drug,Drug Therapy, Aerosol,Inhalation Administration,Administration, Inhalation Drug,Administration, Respiratory Drug,Therapy, Aerosol Drug,Therapy, Drug Aerosol
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D029424 Pulmonary Disease, Chronic Obstructive A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA. Airflow Obstruction, Chronic,COAD,COPD,Chronic Airflow Obstruction,Chronic Obstructive Airway Disease,Chronic Obstructive Lung Disease,Chronic Obstructive Pulmonary Disease,Chronic Obstructive Pulmonary Diseases,Airflow Obstructions, Chronic,Chronic Airflow Obstructions
D036501 Metered Dose Inhalers A small aerosol canister used to release a calibrated amount of medication for inhalation. Inhalers, Metered Dose,Spacer Inhalers,MDI (Inhalers),Spacer-Inhalers,Spinhalers,Inhaler, Metered Dose,Metered Dose Inhaler,Spacer Inhaler,Spacer-Inhaler,Spinhaler

Related Publications

Janine Pilcher, and Mark Weatherall, and Kyle Perrin, and Richard Beasley
January 2014, International journal of chronic obstructive pulmonary disease,
Janine Pilcher, and Mark Weatherall, and Kyle Perrin, and Richard Beasley
May 2008, Ugeskrift for laeger,
Janine Pilcher, and Mark Weatherall, and Kyle Perrin, and Richard Beasley
February 2012, Internal medicine journal,
Janine Pilcher, and Mark Weatherall, and Kyle Perrin, and Richard Beasley
August 2011, Internal medicine journal,
Janine Pilcher, and Mark Weatherall, and Kyle Perrin, and Richard Beasley
October 1999, The European respiratory journal,
Janine Pilcher, and Mark Weatherall, and Kyle Perrin, and Richard Beasley
March 2002, Primary care respiratory journal : journal of the General Practice Airways Group,
Janine Pilcher, and Mark Weatherall, and Kyle Perrin, and Richard Beasley
August 1993, Chest,
Janine Pilcher, and Mark Weatherall, and Kyle Perrin, and Richard Beasley
July 2006, The Cochrane database of systematic reviews,
Janine Pilcher, and Mark Weatherall, and Kyle Perrin, and Richard Beasley
January 2020, The Cochrane database of systematic reviews,
Janine Pilcher, and Mark Weatherall, and Kyle Perrin, and Richard Beasley
June 2011, Der Internist,
Copied contents to your clipboard!